MUSIANI, Piero
 Distribuzione geografica
Continente #
NA - Nord America 6.936
EU - Europa 6.249
AS - Asia 3.901
SA - Sud America 275
Continente sconosciuto - Info sul continente non disponibili 19
AF - Africa 13
OC - Oceania 11
Totale 17.404
Nazione #
US - Stati Uniti d'America 6.864
UA - Ucraina 1.449
CN - Cina 1.393
SG - Singapore 1.137
TR - Turchia 1.034
IE - Irlanda 1.030
GB - Regno Unito 991
SE - Svezia 759
FR - Francia 658
DE - Germania 467
IT - Italia 350
FI - Finlandia 274
BR - Brasile 249
IN - India 228
RU - Federazione Russa 164
CA - Canada 60
CZ - Repubblica Ceca 30
BE - Belgio 29
VN - Vietnam 28
EU - Europa 19
GR - Grecia 18
HK - Hong Kong 18
IL - Israele 16
MX - Messico 10
IQ - Iraq 9
AU - Australia 7
AR - Argentina 6
BD - Bangladesh 6
IR - Iran 6
PK - Pakistan 6
VE - Venezuela 6
ES - Italia 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
LT - Lituania 4
NZ - Nuova Zelanda 4
PY - Paraguay 4
AT - Austria 3
EC - Ecuador 3
EG - Egitto 3
JP - Giappone 3
PL - Polonia 3
RO - Romania 3
ZA - Sudafrica 3
BG - Bulgaria 2
BY - Bielorussia 2
CH - Svizzera 2
KE - Kenya 2
MA - Marocco 2
NL - Olanda 2
PE - Perù 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CL - Cile 1
CO - Colombia 1
EE - Estonia 1
GE - Georgia 1
HU - Ungheria 1
ID - Indonesia 1
JO - Giordania 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
TN - Tunisia 1
Totale 17.404
Città #
Jacksonville 1.443
Chandler 1.249
Dublin 1.025
Southend 818
Singapore 646
Izmir 522
Princeton 492
Nanjing 422
Dearborn 421
Wilmington 346
Cambridge 257
Beijing 218
Ann Arbor 180
Ashburn 162
Nanchang 142
Boardman 139
Woodbridge 130
New York 119
Santa Clara 116
Grevenbroich 99
The Dalles 95
Altamura 94
Shenyang 71
Hebei 67
Tianjin 62
Houston 61
Chieti 58
Jiaxing 55
Kunming 51
Jinan 42
Norwalk 41
Hangzhou 39
Orange 39
Changsha 37
San Mateo 35
Augusta 33
Helsinki 31
Brno 30
Toronto 28
Brussels 27
São Paulo 27
Dong Ket 26
Hefei 26
Los Angeles 25
Grafing 24
Guangzhou 22
London 20
Romola 19
Washington 19
Andover 18
Chicago 18
Ningbo 18
Ottawa 18
Auburn Hills 17
Leawood 17
Hong Kong 16
Milan 16
Rome 14
Lanzhou 13
Zhengzhou 12
Changchun 11
Taizhou 11
Falls Church 10
Düsseldorf 9
Seattle 9
Mexico City 8
Munich 8
Rio de Janeiro 8
San Francisco 8
Simi Valley 8
Bari 7
Lanciano 7
Curitiba 6
Phoenix 6
Sydney 6
Vasto 6
Walnut 6
Baghdad 5
Brasília 5
Brooklyn 5
Frankfurt am Main 5
Fuzhou 5
Haikou 5
Nuremberg 5
Tappahannock 5
Tashkent 5
Baotou 4
Belo Horizonte 4
Boston 4
Campinas 4
Chengdu 4
Ferrara 4
Guarulhos 4
Ankara 3
Ardabil 3
Asunción 3
Baku 3
Cairo 3
Chennai 3
Chongqing 3
Totale 10.555
Nome #
1,2-Dimethylhydrazine-induced colon carcinoma and lymphoma in msh2(-/-) mice. 224
Tamoxifene e quercetina inibiscono la proliferazione di cellule neoplastiche polmonari "non small cell" in coltura e nei tumori primitivi. 196
Role of GM-CSF in cryptogenic organizing pneumonia 140
Ruolo della IL-1 nella regolazione della produzione del TGFbeta1 e della IL-8 nei tumori del polmone "non-small cell". 133
Apoptosi spontanea ed indotta da glicocorticoidi nei linfociti T periferici umani 127
Autoimmune B cell lymphopenia following successful adoptive therapy with telomerase-specific T lymphocytes. 119
Interleukin 1alpha and interleukin 6 promote the in vitro growth of both normal and neoplastic human cervical epithelial cells. 114
Role of cytokines in distribution and differentiation of dendritic cell/Langerhans' cell lineage in human primary carcinomas of the lung. 111
Spontaneous and glucocorticoid-induced apoptosis in human mature T lymphocytes. 109
Transforming growth factor beta1, interleukin-8 and interleukin-1 in human non-small cell lung tumor cell lines and primary tumors. 108
TGF-beta-1 and IL-8 in human long cancer cell lines and primary tumors: constitutive production and modulation by IL-1 107
A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth. 106
A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice. 105
Distribution and phenotype of immune cells in normal human gingiva: active immune response versus unresponsiveness. 102
EDAP a member of TNF ligand superfamily is able to induce macrophage-granulocyte cross-talk. 100
T3 expression by human thymocytes in culture. 100
Interleukin 6 gene transfected mouse mammary adenocarcinoma cells displaying an "in vitro" increased cell growth show an "in vivo" low tumor progression and a high metastatic potential. 99
Growth inhibitory mechanism of quercetin and tamoxifen in human lung cancer cell lines 99
A solid phase radioimmunoassay for the diagnosis of human hydatidosis. 99
A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions. 96
The mature, mitogen-responsive, human thymocyte population comprises two functionally distinct T-cell subsets differing in exogenous interleukin requirements for mitogenesis and in sensitivity to glucocorticoids. 96
Sorafenib's inhibition of prostate cancer growth in transgenic adenocarcinoma mouse prostate mice and its differential effects on endothelial and pericyte growth during tumor angiogenesis. 96
AvidinOX for highly efficient tissue-pretargeted radionuclide therapy. 95
Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin. 94
Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vector. 94
Depletion of stromal and intraepithelial antigen-presenting cells in vervical neoplasia in human immunodificiency virus infection 93
HCG hastens both the development of mammary carcinoma and the metastatization of HCG/LH and ERBB-2 receptor-positive cells in mice. 93
Cellule immunocompetenti associate alla mucosa nella patologia della cervice uterina dei soggetti HIV-infetti 92
Carcinomi polmonari umani: produzione di TGFbeta1 91
Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver 91
The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. 91
In vivo studies of cytokines and growth factors involved in inflammation by using engineered tumor cells as biological minipumps. 90
Polymorphonuclear Leukocyte Apoptosis is Inhibited by Platelet-released mediators, Role of TGFbeta-1 90
INTERACTION WITH TYPE II ESTROGEN BINDING SITES AND ANTIPROLIFERATIVE ACTIVITY OF TAMOXIFEN AND QUERCETIN IN HUMAN NON SMALL CELL LUNG CANCER. 90
A DNA Vaccine against ERBB2 Impairs Chemical Carcinogenesis in Random-Bred Hamsters. 90
BALB-neuT Female Mice as a Dynamic Model of Mammary Cancer 90
Interaction Between Endothelial Cells and the Secreted Cytokine Drives the Fate of An IL4- or An IL 5-Transduced Tumour 88
Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice. 88
Effects of castration on the development of prostate adenocarcinoma from its precursor HGPIN and on the occurrence of androgen-independent poorly differentiated carcinoma in TRAMP mice. 88
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity. 88
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis 88
Tumor cells engineered with IL-12 and IL-15 genes induce protective antibody responses in nude mice. 88
Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression 87
IL-10 potentiates the effect of dexamethasone in inhibiting the proliferation of resting, activated and "corticoresistant" human T cells 87
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy. 86
Androgen Deprivation Boosts Prostatic Infiltration of Cytotoxic and Regulatory T Lymphocytes and Has No Effect on Disease-Free Survival in Prostate Cancer Patients. 86
Analysis of IL-2-receptor expression and of the biological effects of IL-2 gene transfection in small-cell lung cancer. 85
Immune Events Associated with the Cure Established Tumors and Spontaneous Metastases by Local and Systemic Interlukin 12 85
OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor response. 85
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice. 85
Ultrastructural analysis of peripheral blood mononuclear cells in renal allograft recipients. 85
Alterations in thymocyte subpopulations in Down's syndrome (trisomy 21). 85
Growth inhibitory effect of quercetin and tamoxifen and presence of type II estrogen-binding sites in human lung cancer cell lines and primary tumors 84
Proliferative capabilities of T3-positive thymocytes. 84
Interleukin 12-mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice 83
The Immune Response Elicited by Mammary Adenocarcinoma Cells Transduced with Interferon-y and Cytosine Deaminase Genes Cures Lung Metastases by Parental Cells 83
Proliferation of phenotypically immature human thymocytes with and without interleukin 2 receptors. 83
Local release of IL-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti- inflammatory activity resulting in a delayed tumour rejection. 82
Interferon (IFN)-beta Gene Transfer into TS/A Adenocarcinoma Cells and Comparison with IFN-alpha. Differential Effects on Tumorigenicity and Host Response 82
Alloantisera defining surface antigens on human thymocytes. 82
Alpha-1-antitrypsin in umbilical cord serum: pi phenotypes and relationships with idiopathic respiratory distress syndrome. 82
Alpha-1-antitrypsin phenotypes in newborns from Central and Southern Italy. 82
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. 82
Effects of ELF-EMF exposure on haemopoiesis and mammary carcinogenesis in BALB/c mice 81
Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice 81
The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance. 80
Immunopathological alterations of the prostate-associated lymphoid tissue (PALT) by androgen ablation in patients with prostate cancer 80
Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogene. 80
Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice 80
Inactivation of the IL-6 gene prevents development of multricentric Castleman's disease in C/EBP beta-deficient mice 79
Down regulation of major histocompatibility complex class I expression in mammary carcinoma of Her-2/neu trangenic mice 79
Induced somatic inactivation of STAT3 in mice triggers the development of a fulminant form of enterocolitis. 79
Neutrophils in anti-cancer immunological strategies: old players in new games 79
Glucocorticoid inhibitory action on OKT3 stimulated peripheral blood lymphocytes from renal transplant patients. 79
Xenotransplantation rejection is antibody-mediated in both sensitized and nonsensitized recipients. 79
Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway 79
Alpha-l-antitrypsin deficiency and human pathology. 79
WIP null mice display a progressive immunological disorder that resembles Wiskott-Aldrich syndrome. 78
Immune cell characterization and cytokine detection in inflammatory bowel disease. 78
A multi-DNA preventive vaccine for p53/Neu driven cancer syndrome. 78
Echinococcus granulosus: specific quantification of the two most immunoreactive antigens in hydatid fluids. 78
Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes. 77
Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expression. 77
The prostate-associated lymphoid tissue (PALT) is heavily compromised in prostate cancer but differently altered depending on androgen ablation. 77
Inhibitory effect of cyclosporin A on the OKT3-induced peripheral blood lymphocyte proliferation. 77
IL-10 synergizes with dexamethasone in inhibiting human T cell proliferation. 77
Proinflammatory cytokines IL1 and IL6 are autocrine and/or paracrine growth factors for normal and neoplastic epithelial cells from human uterine cervix. 77
Interleukin 6 gene-transfected mouse mammary adenocarcinoma: tumour cell growth and metastatic potential. 76
5-fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory 76
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia. 76
The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice. 76
Antimetastatic activity of a preventive cancer vaccine. 76
Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway. 76
IL-12 mediated prevention of spontaneous tumors in C-neu transgenic inbred BALB/c and FVB mice. 76
Synergistic inhibitory activities of interleukin-10 and dexamethasone on human CD4+ T cells. 76
THE ROLE OF ARACHIDONIC ACID METABOLITE PGE2 ON T CELL PROLIFERATIVE RESPONSE. 75
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent. 75
Hairy cell leukemia. 75
Echinococcus granulosus: preparation of monosepcific antisera against antigens in sheep hydatid fluid. 75
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine. 74
Totale 9.033
Categoria #
all - tutte 69.441
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.441


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020325 0 0 0 0 0 0 0 0 0 0 298 27
2020/20211.618 261 5 246 9 221 340 10 6 135 253 44 88
2021/2022926 18 12 7 122 142 32 33 82 65 30 121 262
2022/20233.423 294 297 164 446 376 773 204 260 446 38 72 53
2023/20241.387 136 49 65 36 104 428 363 40 11 20 14 121
2024/20252.285 224 489 401 75 63 49 36 238 392 150 168 0
Totale 17.710